ロタウイルスワクチンの世界市場レポート 2025年

ロタウイルスワクチンの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は10.2％で、149億6,000万米ドルに成長します。予測期間の成長は、出生率の上昇、予防接種プログラムの拡大、予防ヘルスケアへの注目の高まり、経済成長とアクセス改善、政府の政策と資金援助などに起因すると考えられます。予測期間における主な動向としては、ワクチン技術の進歩、経口投与技術の進歩、ワクチン製剤の改良、混合ワクチン、デジタルヘルス統合などが挙げられます。

出生率の増加は、今後のロタウイルスワクチン市場の成長を牽引すると予想されます。出生率は、特定の期間における人口1,000人当たりの出生数を示すもので、経済的安定や成長、育児休暇や児童手当、育児補助金などの支援政策などの要因に影響されます。ロタウイルスワクチンは、乳幼児の重症ロタウイルス胃腸炎を減少させ、小児の健康状態の改善とロタウイルス感染症に関連するヘルスケアコストの削減につながる重要な役割を担っています。例えば、米国疾病予防管理センター（CDC）の2023年1月の報告によると、米国では出生登録数が前年比1％増の366万4,292人となりました。その結果、出生率の上昇がロタウイルスワクチンの需要を押し上げると予想されます。

ロタウイルスワクチン市場の主要プレーヤーは、ワクチンの送達効率を改善し、患者のコンプライアンスを高めるために、経口投与アプリケーターに注目しています。経口投与アプリケータは、液体薬剤やワクチンを直接口に投与するように設計された装置であり、特に乳幼児にとっては正確な投与量と使いやすさが保証されます。例えば、2022年11月、英国の製薬・バイオテクノロジー企業であるGSK plcは、ロタリックス（ロタウイルスワクチン, Live, Oral）の新しい経口投与アプリケーター専用製剤のFDA承認を取得しました。この製剤は、乳幼児のG1型および非G1型（G3、G4、G9）によるロタウイルス胃腸炎に有効であり、用量の再構成が不要なため、ヘルスケア提供者のワクチン調製が簡素化されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ロタウイルスワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のロタウイルスワクチン市場：成長率分析
• 世界のロタウイルスワクチン市場の実績：規模と成長, 2019-2024
• 世界のロタウイルスワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界ロタウイルスワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のロタウイルスワクチン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ロタリックス
• ロタテック
• ロータバック
• ロタビンM1
• 蘭州ラム
• その他のタイプ
• 世界のロタウイルスワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 成人用
• 小児科
• 世界のロタウイルスワクチン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 学術調査
• 世界のロタウイルスワクチン市場ロタリックスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 投与スケジュールと投与方法
• 有効性と安全性のプロファイル
• ターゲット層
• 世界のロタウイルスワクチン市場RotaTeqのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 投与スケジュールと投与方法
• 有効性と安全性のプロファイル
• ターゲット層
• 世界のロタウイルスワクチン市場ロータリー式掃除機の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 投与スケジュールと投与方法
• 有効性と安全性のプロファイル
• ターゲット層
• 世界のロタウイルスワクチン市場ロタビンM1のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 投与スケジュールと投与方法
• 有効性と安全性のプロファイル
• ターゲット層
• 世界のロタウイルスワクチン市場蘭州ラムの種類別細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 投与スケジュールと投与方法
• 有効性と安全性のプロファイル
• ターゲット層
• 世界のロタウイルスワクチン市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新たなロタウイルスワクチン
• 混合ワクチン
• 地域特有のワクチン

第7章 地域別・国別分析

• 世界のロタウイルスワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のロタウイルスワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ロタウイルスワクチン市場：競合情勢
• ロタウイルスワクチン市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Serum Institute of India Private Limited
• Sinovac Biotech Ltd.
• SK Chemicals Co Ltd
• Bharat Biotech International Limited
• Walvax Biotechnology Co. Ltd.
• Indian Immunologicals Limited
• PT Bio Farma
• KFF Inc.
• Panacea Biotec Limited
• Sanyou Biopharmaceuticals Co. Ltd.
• Inovio Pharmaceuticals Inc.
• Hilleman Laboratories Private Limited
• China National Biotec Group Corporation
• Vabiotech
• Lanzhou Institute of Biological Products Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ロタウイルスワクチン市場2029：新たな機会を提供する国
• ロタウイルスワクチン市場2029：新たな機会を提供するセグメント
• ロタウイルスワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The rotavirus vaccine is designed to protect against rotavirus infections, which are a common cause of severe diarrhea and gastroenteritis in infants and young children. Administered orally, this vaccine contains live attenuated or inactivated strains of the rotavirus to stimulate an immune response and provide immunity against the virus.

The main types of rotavirus vaccines include rotarix, rotaTeq, rotavac, rotavin-M1, lanzhou lamb, and others. Rotarix is a live attenuated oral vaccine aimed at protecting infants from rotavirus gastroenteritis, which can lead to severe diarrhea and dehydration. The vaccine is used in both pediatric and adult applications, with end users including hospitals, clinics, and academic research institutions.

The rotavirus vaccine market research report is one of a series of new reports from the business research company that provides rotavirus vaccine market statistics, including rotavirus vaccine industry global market size, regional shares, competitors with an rotavirus vaccine market share, detailed rotavirus vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the rotavirus vaccine industry. This rotavirus vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rotavirus vaccine market size has grown rapidly in recent years. It will grow from $9.18 billion in 2024 to $10.14 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased awareness of rotavirus, improved healthcare infrastructure, government immunization programs, rising incidence of rotavirus infections, rising birth rates.

The rotavirus vaccine market size is expected to see rapid growth in the next few years. It will grow to $14.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising birth rates, the expansion of vaccination programs, an increased focus on preventive healthcare, economic growth and improved access, and government policies and funding. Major trends in the forecast period include advancements in vaccine technology, advancements in oral-dosing technologies, improved vaccine formulations, combination vaccines, and digital health integration.

The increasing birth rates are expected to drive the growth of the rotavirus vaccine market in the future. Birth rates, which measure the number of live births per 1,000 people in a given population over a specific period, are influenced by factors such as economic stability, growth, and supportive policies such as parental leave, child benefits, and childcare subsidies. Rotavirus vaccines play a crucial role in reducing severe rotavirus gastroenteritis in infants, leading to improved child health outcomes and lower healthcare costs related to rotavirus infections. For example, according to a January 2023 report by the Centers for Disease Control and Prevention (CDC), the United States experienced a 1% increase in registered births, totaling 3,664,292, compared to the previous year. Consequently, the rise in birth rates is expected to boost the demand for rotavirus vaccines.

Key players in the rotavirus vaccine market are focusing on oral-dosing applicators to improve vaccine delivery efficiency and enhance patient compliance. Oral-dosing applicators are devices designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and ease of use, especially for infants and young children. For instance, in November 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, received FDA approval for a new oral-dosing applicator-only formulation of ROTARIX (Rotavirus Vaccine, Live, Oral). This formulation is effective against rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in infants and simplifies vaccine preparation for healthcare providers by removing the need for dose reconstitution.

In June 2024, Murdoch Children's Research Institute, an Australia-based child health research organization, partnered with Incepta Pharmaceuticals Limited. This collaboration aims to enhance protection for children against rotavirus by developing and distributing effective vaccines. The partnership focuses on expanding access to essential rotavirus vaccines in regions with high infection rates and limited healthcare resources. Incepta Pharmaceuticals Limited, a Bangladesh-based pharmaceutical company, is involved in the development of rotavirus vaccines.

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

North America was the largest region in the rotavirus vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rotavirus vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rotavirus vaccine market consists of sales of combination vaccines, vaccine delivery systems, vaccine doses, and packs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rotavirus Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rotavirus vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rotavirus vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rotavirus vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Rotarix; RotaTeq; Rotavac; Rotavin-M1; Lanzhou lamb; Other Types
• 2) By Application: Adult; Pediatric
• 3) By End Users: Hospitals; Clinics; Academic Research
• Subsegments:
• 1) By Rotarix: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
• 2) By RotaTeq: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
• 3) By Rotavac: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
• 4) By Rotavin-M1: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
• 5) By Lanzhou Lamb: Dosing Schedule And Administration; Efficacy And Safety Profile; Target Demographics
• 6) By Other Types: Emerging Rotavirus Vaccines; Combination Vaccines; Region-Specific Vaccines
• Companies Mentioned: Merck & Co. Inc.; Sanofi S.A.; Abbott Laboratories; GlaxoSmithKline plc; Daiichi Sankyo Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rotavirus Vaccine Market Characteristics

3. Rotavirus Vaccine Market Trends And Strategies

4. Rotavirus Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Rotavirus Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rotavirus Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rotavirus Vaccine Market Growth Rate Analysis
• 5.4. Global Rotavirus Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rotavirus Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rotavirus Vaccine Total Addressable Market (TAM)

6. Rotavirus Vaccine Market Segmentation

• 6.1. Global Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rotarix
• RotaTeq
• Rotavac
• Rotavin-M1
• Lanzhou lamb
• Other Types
• 6.2. Global Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult
• Pediatric
• 6.3. Global Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Academic Research
• 6.4. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotarix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dosing Schedule And Administration
• Efficacy And Safety Profile
• Target Demographics
• 6.5. Global Rotavirus Vaccine Market, Sub-Segmentation Of RotaTeq, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dosing Schedule And Administration
• Efficacy And Safety Profile
• Target Demographics
• 6.6. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotavac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dosing Schedule And Administration
• Efficacy And Safety Profile
• Target Demographics
• 6.7. Global Rotavirus Vaccine Market, Sub-Segmentation Of Rotavin-M1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dosing Schedule And Administration
• Efficacy And Safety Profile
• Target Demographics
• 6.8. Global Rotavirus Vaccine Market, Sub-Segmentation Of Lanzhou Lamb, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dosing Schedule And Administration
• Efficacy And Safety Profile
• Target Demographics
• 6.9. Global Rotavirus Vaccine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Emerging Rotavirus Vaccines
• Combination Vaccines
• Region-Specific Vaccines

7. Rotavirus Vaccine Market Regional And Country Analysis

• 7.1. Global Rotavirus Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rotavirus Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rotavirus Vaccine Market

• 8.1. Asia-Pacific Rotavirus Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rotavirus Vaccine Market

• 9.1. China Rotavirus Vaccine Market Overview
• 9.2. China Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rotavirus Vaccine Market

• 10.1. India Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rotavirus Vaccine Market

• 11.1. Japan Rotavirus Vaccine Market Overview
• 11.2. Japan Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rotavirus Vaccine Market

• 12.1. Australia Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rotavirus Vaccine Market

• 13.1. Indonesia Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rotavirus Vaccine Market

• 14.1. South Korea Rotavirus Vaccine Market Overview
• 14.2. South Korea Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rotavirus Vaccine Market

• 15.1. Western Europe Rotavirus Vaccine Market Overview
• 15.2. Western Europe Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rotavirus Vaccine Market

• 16.1. UK Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rotavirus Vaccine Market

• 17.1. Germany Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rotavirus Vaccine Market

• 18.1. France Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rotavirus Vaccine Market

• 19.1. Italy Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rotavirus Vaccine Market

• 20.1. Spain Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rotavirus Vaccine Market

• 21.1. Eastern Europe Rotavirus Vaccine Market Overview
• 21.2. Eastern Europe Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rotavirus Vaccine Market

• 22.1. Russia Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rotavirus Vaccine Market

• 23.1. North America Rotavirus Vaccine Market Overview
• 23.2. North America Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rotavirus Vaccine Market

• 24.1. USA Rotavirus Vaccine Market Overview
• 24.2. USA Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rotavirus Vaccine Market

• 25.1. Canada Rotavirus Vaccine Market Overview
• 25.2. Canada Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rotavirus Vaccine Market

• 26.1. South America Rotavirus Vaccine Market Overview
• 26.2. South America Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rotavirus Vaccine Market

• 27.1. Brazil Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rotavirus Vaccine Market

• 28.1. Middle East Rotavirus Vaccine Market Overview
• 28.2. Middle East Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rotavirus Vaccine Market

• 29.1. Africa Rotavirus Vaccine Market Overview
• 29.2. Africa Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rotavirus Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Rotavirus Vaccine Market Competitive Landscape
• 30.2. Rotavirus Vaccine Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Rotavirus Vaccine Market Other Major And Innovative Companies

• 31.1. Serum Institute of India Private Limited
• 31.2. Sinovac Biotech Ltd.
• 31.3. SK Chemicals Co Ltd
• 31.4. Bharat Biotech International Limited
• 31.5. Walvax Biotechnology Co. Ltd.
• 31.6. Indian Immunologicals Limited
• 31.7. PT Bio Farma
• 31.8. KFF Inc.
• 31.9. Panacea Biotec Limited
• 31.10. Sanyou Biopharmaceuticals Co. Ltd.
• 31.11. Inovio Pharmaceuticals Inc.
• 31.12. Hilleman Laboratories Private Limited
• 31.13. China National Biotec Group Corporation
• 31.14. Vabiotech
• 31.15. Lanzhou Institute of Biological Products Co. Ltd.

32. Global Rotavirus Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rotavirus Vaccine Market

34. Recent Developments In The Rotavirus Vaccine Market

35. Rotavirus Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Rotavirus Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rotavirus Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rotavirus Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33547_Rotavirus_Vaccine_GMR_2025